Rachel Zabner

813 citations
15 papers · 348 indexed · h-index 9

Rachel Zabner

15 papers receiving 341 citations

Peers

Rachel Zabner
Comparison fields: 5 of 61
  • Infectious Diseases 133
  • Critical Care and Intensive Care Medicine 37
  • Neurology 80
  • Epidemiology 129
  • Transplantation 9
Replace Dipen Kadaria with:
Dipen Kadaria United States
Yascha Khodamoradi Germany
Alexandre Carvalho Portugal
Vincenzo Sangiovanni Italy
P. Viale Italy
Miguel Ángel Salazar-Lezama Mexico
Charlotte Pronier France
Sara Cajander Sweden
Hiroshi Moro Japan
Hideaki Oka Japan
Rachel Zabner relative to Dipen Kadaria United States Dipen Kadaria's profile →
Citations per field
00.5×2.8×
Dipen Kadaria · 1×
Citations per year

Countries citing papers authored by Rachel Zabner

Since Specialization
Citations

This map shows the geographic impact of Rachel Zabner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Zabner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Zabner more than expected).

Fields of papers citing papers by Rachel Zabner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Zabner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Zabner. The network helps show where Rachel Zabner may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rachel Zabner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rachel Zabner Line = papers co-authored together Rachel Zabner links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 202243
2 20221
3 20211
4 202031
5 202055
6 20192
7 20186
8 20169
9 201612
10 201347
11 20001
12 200047
13
NCCN practice guidelines for fever and neutropenia
199918
14 199667
15
Antimicrobials in cystic fibrosis: emergence of resistance and implications for treatment.
19928

About Rachel Zabner

Rachel Zabner is a scholar working on Transplantation, Emergency Medicine and Critical Care and Intensive Care Medicine, having authored 15 papers that have together received 348 indexed citations. Recurring topics across this work include Polyomavirus and related diseases (3 papers), Mosquito-borne diseases and control (2 papers), Neutropenia and Cancer Infections (2 papers), Long-Term Effects of COVID-19 (2 papers), Hallucinations in medical conditions (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Virus-based gene therapy research (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Infectious Diseases (133 citations), Critical Care and Intensive Care Medicine (37 citations) and Neurology (80 citations). Rachel Zabner has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Marleen Irwin, Paul M. Arnow, Amrita Krishnan, John A. Zaia, Arturo Molina, Auayporn Nademanee, Irena Sniecinski, Stephen J. Forman, P. Zakowski and L. Czer. Their work appears in journals such as Cancer, Clinical Infectious Diseases and American Journal of Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026